Explore more publications!
Health & Wellness Today New York
Got News to Share?

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on January 19, 2026

Dr. Joel Durinka Announces Scholarship for Aspiring Physicians
Jan. 19, 2026

Dr. Joel Durinka Announces Scholarship for Aspiring Physicians

Indeterminate EIN Presswire
Canadian Association of Occupational Therapy and Speech-Language & Audiology Canada Call for Action as Delays Under Jordan’s Principle and the Inuit Child First Initiative Deny First Nations and Inuit Children Access to Essential Care
Jan. 19, 2026

Canadian Association of Occupational Therapy and Speech-Language & Audiology Canada Call for Action as Delays Under Jordan’s Principle and the Inuit Child First Initiative Deny First Nations and Inuit Children Access to Essential Care

Indeterminate GlobeNewswire
Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
Jan. 19, 2026

Valneva Provides Update on Chikungunya Vaccine IXCHIQ®

Indeterminate GlobeNewswire
Valneva fait un point sur son vaccin contre le chikungunya IXCHIQ®
Jan. 19, 2026

Valneva fait un point sur son vaccin contre le chikungunya IXCHIQ®

Indeterminate GlobeNewswire
Advancing Quality of Life for Deaf and Hard of Hearing Communities: Canadian Hearing Services Awards Four New Research Grants
Jan. 19, 2026

Advancing Quality of Life for Deaf and Hard of Hearing Communities: Canadian Hearing Services Awards Four New Research Grants

Indeterminate GlobeNewswire
BVI Appoints Jim Hollingshead as President & Chief Executive Officer
Jan. 19, 2026

BVI Appoints Jim Hollingshead as President & Chief Executive Officer

Indeterminate GlobeNewswire
Kaléo Strengthens Leadership Team to Advance Drug Delivery and Autoinjector Innovation
Jan. 19, 2026

Kaléo Strengthens Leadership Team to Advance Drug Delivery and Autoinjector Innovation

Indeterminate GlobeNewswire
MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
Jan. 19, 2026

MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO

Indeterminate GlobeNewswire
CUKTECH Launches 30 Ultra Charging Station in Malaysia, Redefining the Desktop Charging Experience
Jan. 19, 2026

CUKTECH Launches 30 Ultra Charging Station in Malaysia, Redefining the Desktop Charging Experience

Indeterminate GlobeNewswire
CUKTECH Melancarkan Stesen Pengecasan 30 Ultra di Malaysia, Mentakrifkan Semula Pengalaman Pengecasan Desktop
Jan. 19, 2026

CUKTECH Melancarkan Stesen Pengecasan 30 Ultra di Malaysia, Mentakrifkan Semula Pengalaman Pengecasan Desktop

Indeterminate GlobeNewswire
Blockchain Technology in Healthcare Market to Reach USD 345.89 Billion by 2032 at 63.90% CAGR, Driven by Rising Demand for Privacy Compliance: AnalystView Market Insights
Jan. 19, 2026

Blockchain Technology in Healthcare Market to Reach USD 345.89 Billion by 2032 at 63.90% CAGR, Driven by Rising Demand for Privacy Compliance: AnalystView Market Insights

Indeterminate GlobeNewswire
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
Jan. 19, 2026

Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea

Indeterminate GlobeNewswire
Concept Life Sciences Appoints Dr Adam Davenport as CSO to Strengthen Leadership in Integrated Drug Discovery
Jan. 19, 2026

Concept Life Sciences Appoints Dr Adam Davenport as CSO to Strengthen Leadership in Integrated Drug Discovery

Indeterminate GlobeNewswire
FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy
Jan. 19, 2026

FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions